Navigation Links
Organovo Announces Collaboration with National Institutes of Health
Date:1/14/2014

and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including our report on Form 10-Q filed November 8, 2013, the prospectus supplement filed with the SEC on August 2, 2013 and the transition report on Form 10-KT filed with the SEC on May 24, 2013 and our other filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
2. Organovo Reports Q1 Fiscal 2014 Results, Provides Business Update
3. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
4. Organovo Announces the Nomination of Richard A. Heyman to Board of Directors
5. Organovo Rings Opening Bell On New York Stock Exchange
6. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
7. Organovo To List Common Stock On New York Stock Exchange MKT
8. Organovo Appoints Tamar D. Howson to Board of Directors
9. Organovo to Present at the 12th Annual Needham Healthcare Conference
10. Organovo Partners With ZenBio to Create 3D Tissue Models
11. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... granted to German life sciences entrepreneurs with a ... of biotechnology (collectively, the "Optionee"), an option to ... vaccine technology (the "Technology"), including AEZS-120, the most ... ready to enter a Phase 1 clinical trial. ...
(Date:7/28/2015)... , July 28, 2015  Faced with increasing ... are palliative rather than symptomatic, the global healthcare ... existing therapies capable of curing or significantly changing ... starting to look towards regenerative medicine as a ... new paradigm in human health with the potential ...
(Date:7/27/2015)... - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the ... the treatment of cancer, today provides the following financial ... a $1,000,000 unit offering private placement.  This financing is ... Company at a price of $0.06 per unit.  Each ... common share purchase warrant.  Each whole warrant is exercisable ...
(Date:7/27/2015)... ... July 27, 2015 , ... Brady ... a new video: 3 Ways to GHS Labels . This video provides ... Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With the fourth ...
Breaking Biology Technology:Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5Quest PharmaTech Closes $1,000,000 Private Placement 2Brady Releases “3 Roads to GHS Labels” Video 2
... NEW YORK, Sept. 8 Reportlinker.com announces that ... , , Small Molecule Kinase ... http://www.reportlinker.com/p0131227/Small-Molecule-Kinase-Inhibitors.html , , ... Inhibitors in Millions of US$ by the following Product Segments: ...
... , , , Dan ... PHILADELPHIA, Sept. 8 PriceSpective, a value strategy consultancy that ... pleased to announce that it has hired Dan Ross to open ... brings 9 years of experience working with healthcare companies in both ...
... , , ... (Nasdaq: PPHM ) today reported completion of patient enrollment ... and paclitaxel in advanced breast cancer patients. The trial,s planned ... undergoing treatment and follow-up. The primary objective of the multi-center, ...
Cached Biology Technology:Reportlinker Adds Small Molecule Kinase Inhibitors Report 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 3Reportlinker Adds Small Molecule Kinase Inhibitors Report 4Reportlinker Adds Small Molecule Kinase Inhibitors Report 5Reportlinker Adds Small Molecule Kinase Inhibitors Report 6Reportlinker Adds Small Molecule Kinase Inhibitors Report 7Reportlinker Adds Small Molecule Kinase Inhibitors Report 8Reportlinker Adds Small Molecule Kinase Inhibitors Report 9Reportlinker Adds Small Molecule Kinase Inhibitors Report 10PriceSpective Continues Global Expansion With New San Diego Office 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 5
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... The world,s most powerful neutron source should be built in ... At a meeting in Brussels last night (28 May), ... the European Spallation Source (ESS), with a further two voting ... be the world,s most advanced centre for materials research, enabling ...
... say they,ve made a big improvement in a new breed ... one that may be a valuable addition to the battle ... antibody attached to a nanowire that,s attached to an electrical ... binds to is present in the liquid, it will bind ...
... Animals can simplify the brain control of their limb ... that operates against a spring made of the almost ... and illustrated by striking photographs and high-speed video footage, ... , of the movements of the mouthparts of crabs ...
Cached Biology News:Sweden to host 1.3 billion Euro research center 2A quicker, cheaper SARS virus detector -- one easily customizable for other targets 2Resilin springs simplify the control of crustacean limb movements 2
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Assay Diluent 500 mls...
Mouse monoclonal [4C4] to Y14 ( Abpromise for all tested applications). entrezGeneID: 9939 SwissProtID: Q9Y5S9...
Biology Products: